Although knockdown of the key ISR mediator Chop had no effect on motor deficits and did not ameliorate overall TDP-43 pathology in rNLS8 mice, our findings indicate that targeting of cell stress and death signalling may be a potential promising avenue for treatment of TDP-43-associated ALS and FTD. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.